Stock Track | Teladoc Health Plunges 16% After Q4 Earnings Miss and Weak Guidance

Stock Track

Feb 27

Teladoc Health Inc. (TDOC) shares plummeted 16.01% in the after-hours session on Wednesday following the company's disappointing fourth-quarter 2024 earnings report and weak outlook for 2025.

The virtual healthcare provider reported a quarterly loss of $0.28 per share, missing Wall Street's expectations of a $0.23 per share loss. While Teladoc's revenue of $640.5 million for the quarter narrowly beat estimates, the larger-than-expected loss overshadowed the positive revenue surprise.

The earnings miss was driven by a decline in Teladoc's BetterHelp mental health segment, which saw revenue drop 10% due to decreased demand for direct mental health services. Additionally, the company's gross margin slipped to 65.7% from 68.8% a year earlier, and adjusted EBITDA declined across segments.

Looking ahead, Teladoc's guidance for 2025 fell short of analysts' projections. The company expects revenue between $2.468 billion and $2.576 billion, compared to $2.570 billion in 2024. Its adjusted EBITDA forecast range of $278 million to $319 million is largely below the $310.7 million reported in 2024.

The disappointing results and lackluster outlook weighed heavily on Teladoc's stock, with investors punishing the virtual healthcare leader amid intense competition and concerns over slowing demand for its services.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1157879900"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1157879900\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1157879900?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-27 09:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157879900","market":"hk","top_or_hot":-1,"title":"Stock Track | Teladoc Health Plunges 16% After Q4 Earnings Miss and Weak Guidance","media":"Stock Track","content":"<p>Teladoc Health Inc. (TDOC) shares plummeted 16.01% in the after-hours session on Wednesday following the company's disappointing fourth-quarter 2024 earnings report and weak outlook for 2025.</p>\n\n<p>The virtual healthcare provider reported a quarterly loss of $0.28 per share, missing Wall Street's expectations of a $0.23 per share loss. While Teladoc's revenue of $640.5 million for the quarter narrowly beat estimates, the larger-than-expected loss overshadowed the positive revenue surprise.</p>\n\n<p>The earnings miss was driven by a decline in Teladoc's BetterHelp mental health segment, which saw revenue drop 10% due to decreased demand for direct mental health services. Additionally, the company's gross margin slipped to 65.7% from 68.8% a year earlier, and adjusted EBITDA declined across segments.</p>\n\n<p>Looking ahead, Teladoc's guidance for 2025 fell short of analysts' projections. The company expects revenue between $2.468 billion and $2.576 billion, compared to $2.570 billion in 2024. Its adjusted EBITDA forecast range of $278 million to $319 million is largely below the $310.7 million reported in 2024.</p>\n\n<p>The disappointing results and lackluster outlook weighed heavily on Teladoc's stock, with investors punishing the virtual healthcare leader amid intense competition and concerns over slowing demand for its services.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Teladoc Health Plunges 16% After Q4 Earnings Miss and Weak Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Teladoc Health Plunges 16% After Q4 Earnings Miss and Weak Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-27 09:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Teladoc Health Inc. (TDOC) shares plummeted 16.01% in the after-hours session on Wednesday following the company's disappointing fourth-quarter 2024 earnings report and weak outlook for 2025.</p>\n\n<p>The virtual healthcare provider reported a quarterly loss of $0.28 per share, missing Wall Street's expectations of a $0.23 per share loss. While Teladoc's revenue of $640.5 million for the quarter narrowly beat estimates, the larger-than-expected loss overshadowed the positive revenue surprise.</p>\n\n<p>The earnings miss was driven by a decline in Teladoc's BetterHelp mental health segment, which saw revenue drop 10% due to decreased demand for direct mental health services. Additionally, the company's gross margin slipped to 65.7% from 68.8% a year earlier, and adjusted EBITDA declined across segments.</p>\n\n<p>Looking ahead, Teladoc's guidance for 2025 fell short of analysts' projections. The company expects revenue between $2.468 billion and $2.576 billion, compared to $2.570 billion in 2024. Its adjusted EBITDA forecast range of $278 million to $319 million is largely below the $310.7 million reported in 2024.</p>\n\n<p>The disappointing results and lackluster outlook weighed heavily on Teladoc's stock, with investors punishing the virtual healthcare leader amid intense competition and concerns over slowing demand for its services.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TDOC","symbol_name":"Teladoc Health Inc.","start_time":0,"source_url":"","article_id":"1157879900","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157879900","pubTimestamp":1740618449,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Teladoc Health Inc.  shares plummeted 16.01% in the after-hours session on Wednesday following the company's disappointing fourth-quarter 2024 earnings report and weak outlook for 2025.The virtual healthcare provider reported a quarterly loss of $0.28 per share, missing Wall Street's expectations of a $0.23 per share loss. While Teladoc's revenue of $640.5 million for the quarter narrowly beat estimates, the larger-than-expected loss overshadowed the positive revenue surprise.The earnings miss w","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TDOC":"Teladoc Health Inc."},"translate_title":"Teladoc Health第四季度盈利未达预期且指引疲弱，股价暴跌16%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TDOC":1},"content_text":"Teladoc Health Inc. (TDOC) shares plummeted 16.01% in the after-hours session on Wednesday following the company's disappointing fourth-quarter 2024 earnings report and weak outlook for 2025.\nThe virtual healthcare provider reported a quarterly loss of $0.28 per share, missing Wall Street's expectations of a $0.23 per share loss. While Teladoc's revenue of $640.5 million for the quarter narrowly beat estimates, the larger-than-expected loss overshadowed the positive revenue surprise.\nThe earnings miss was driven by a decline in Teladoc's BetterHelp mental health segment, which saw revenue drop 10% due to decreased demand for direct mental health services. Additionally, the company's gross margin slipped to 65.7% from 68.8% a year earlier, and adjusted EBITDA declined across segments.\nLooking ahead, Teladoc's guidance for 2025 fell short of analysts' projections. The company expects revenue between $2.468 billion and $2.576 billion, compared to $2.570 billion in 2024. Its adjusted EBITDA forecast range of $278 million to $319 million is largely below the $310.7 million reported in 2024.\nThe disappointing results and lackluster outlook weighed heavily on Teladoc's stock, with investors punishing the virtual healthcare leader amid intense competition and concerns over slowing demand for its services.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}